High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients-Reference-Cited by-同舟云学术

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

Published:2006-12 Issue:12 Volume:81 Page:973-978
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Martino Massimo,Console Giuseppe,Irrera Giuseppe,Praticò Giulia,Stelitano Caterina,Callea Vincenzo,Morabito Fortunato,Quartarone Eugenia,Musolino Caterina,Piro Eugenio,Brugiatelli Maura,Iacopino Pasquale

Publisher

Wiley

Subject

Hematology

Reference24 articles.

1. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

2. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

3. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

4. Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial

5. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities;Oncology Reviews;2012-10-04

2. A Phase II Trial of Autologous Stem Cell Transplantation Followed by Mini-Allogeneic Stem Cell Transplantation for the Treatment of Multiple Myeloma: An Analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97;Biology of Blood and Marrow Transplantation;2009-01

3. Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Drugs;Journal of Clinical Oncology;2008-01-20

4. Allogeneic Transplantation for Multiple Myeloma;Myeloma Therapy;2008

5. Current Awareness in Hematological Oncology;Hematological Oncology;2007